Effect of Intraoperative Opioid Dose on Perioperative Neutrophil-to-Lymphocyte Ratio and Lymphocyte-to-Monocyte Ratio in Glioma
Xuejiao Liu,Lei Teng,Junzhu Dai,Hongxue Shao,Rui Chen,Haixiang Li,Jing Li,Huichao Zou
DOI: https://doi.org/10.2147/jir.s451455
IF: 4.5
2024-04-10
Journal of Inflammation Research
Abstract:Xuejiao Liu, Lei Teng, Junzhu Dai, Hongxue Shao, Rui Chen, Haixiang Li, Jing Li, Huichao Zou Department of Pain Medicine, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, People's Republic of China Correspondence: Huichao Zou, Email Background: The neutrophil-to-lymphocyte ratio (NLR) and lymphocyte-to-monocyte ratio (LMR) are inflammatory biomarkers. Until now, it is unknown the impact of opioid dosage on perioperative immunity in glioma patients. The aim of this study was to explore the effect of intraoperative opioid dosage on perioperative immune perturbations using NLR and LMR as inflammatory biomarkers and evaluate the correlation between inflammatory biomarkers and pathological grade of glioma. Methods: The study included 208 patients with primary glioma who underwent glioma resection from February 2012 to November 2019 at Harbin Medical University Cancer Hospital. Complete blood count (CBC) was collected at 3 time points: one week before surgery, and 24 hours and one week after surgery. Patients were divided into high-dose and low-dose groups, based on the median value of intraoperative opioid dose. The relationships between perioperative NLR, LMR and intraoperative opioid dosage were analyzed using repeated measurement analysis of variance (ANOVA). Correlations between preoperative various factors and pathological grade were analyzed by Spearman analysis. Receiver operating characteristic (ROC) curves were performed to assess the predictive performance of the NLR and LMR for pathological grade. Results: The NLR ( P =0.020) and lower LMR ( P =0.037) were statistically significant different between high-dose and low-dose groups one week after surgery. The area under the curve (AUC) of the NLR to identify poor diagnosis was 0.685, which was superior to the LMR (AUC: 0.607) and indicated a correlation between the NLR with pathological grade. The preoperative NLR ( P =0.000), LMR ( P =0.009), age ( P =0.000) and tumor size ( P =0.001) exhibited a significant correlation with the pathological grade of glioma. Conclusion: Intraoperative opioids in the high-dose group were associated with higher NLR and lower LMR in postoperative glioma patients. The preoperative NLR and LMR demonstrated predictive value for distinguishing between high-grade and low-grade gliomas. Keywords: glioma, intraoperative opioid dosage, neutrophil-to-lymphocyte ratio, lymphocyte-to-monocyte ratio, pathological grade Glioma is the most common primary malignant tumor of the brain. 1 The prognosis of high-grade glioma is poor despite combination therapy of surgery, chemotherapy and radiotherapy. Perioperative factors such as intraoperative blood transfusion and methods of anesthesia may have impact on the prognosis of patients. Studies have found that higher doses of intraoperative opioids are associated with lower overall survival in patients with stage I non-small cell lung cancer 2 and kidney cancer. 3 Opioids may suppress immunity, forming a microenvironment that promotes tumor progression. Opioids exert an impact on various components of the immune system, encompassing NK cell function, macrophage proliferation, phagocytic activity and lymphocyte function. 4 The pivotal role of NK cells in innate immunity is widely acknowledged, as they orchestrate early defense mechanisms through their innate cytotoxicity against both microbial-infected and malignant-transformed cells. 5,6 The cytotoxicity of human NK cells was found to be inhibited upon exposure to various opioids commonly used in clinical settings. 7 Studies have demonstrated that long-term opioids impair the macrophages' ability to defend against invading pathogens both in vitro and in vivo. 8 The impact on lymphocytes primarily manifests as the suppression of both T and B lymphocyte function and quantity. Inflammation plays an important role in the occurrence of tumor and the progression of cancer. 9,10 The pathogenesis of cancer shares many similarities with the processes of inflammation and wound healing. 6 Inflammation represents an intrinsic defensive response triggered by detrimental stimuli and neoplastic cells, serving as a pivotal mechanism to eradicate the initial cause of cellular injury, eliminate necrotic cells and damaged tissues, and initiate tissue regeneration. While acute inflammation confers advantageous protection against infections or injuries and preneoplastic cells, it is imperative for this immune reaction to terminate upon completion of its purpose in order to prevent chronic inflammation, which could potentially facilitate tumor initiation and metastasis. 11,12 The presence of numerous triggers for chronic in -Abstract Truncated-
immunology